Categories: News

Cambium Ranked Among Top 100 Venture-Funded, Defense and Dual-Use Start-ups

EL SEGUNDO, Calif., July 16, 2024 /PRNewswire/ — Cambium, an advanced materials innovator that leverages bio-engineering, chemistry, materials science and proprietary computation for defense and other high-performance applications, has been named one of the Top 100 venture-funded national security-focused and dual-use start-ups by the Silicon Valley Defense Group (SVDG) in its annual NATSEC100 report.

This annual ranking and report, sponsored by JPMorganChase’s Aerospace & Defense Industry division, is SVDG’s annual ranked list of the emerging US techno-security ecosystem of venture-backed companies. The ranking is the product of a proprietary, quantitative formula created by SVDG, in collaboration with Franklin Templeton and Balyasny Asset Management, fortified by conversations with technology leaders across the US Government and allied partner governments, and categorized against the US Department of Defense’s 14 Critical Technology Areas.

NATSEC100 companies raised more than $52 billion private funding as of June 2024, a 20% increase over the $42 billion raised by last year’s NATSEC100 companies. The report also notes that Advanced Materials ranked #4 on the 2024 NATSEC100 Tech Categories and that El Segundo, California, where Cambium is headquartered, is now ranked #4 in the top NATSEC100 cities category.

Cambium co-founder and CEO Simon Waddington said, “We are extremely honored to make the NATSEC100 and to be recognized alongside other emerging leaders in supporting our defense and industrial base. Cambium is committed to addressing critical advanced material capability and supply chain gaps to support current and future high-performance hardware needs across land, air, sea and space applications, innovations that are widely applicable outside defense, from commercial aerospace to renewable energy. We are grateful for the support of our venture backers and our Defense Prime Contractors and DoD partners who have recognized the value of Cambium’s transformational development platform and products.”    

About Cambium

We are a radically different advanced materials company. From molecular discovery to materials manufacturing, we leverage AI and informatics to develop and produce truly innovative products for high-performance applications such as monomers, high-temperature composites and foams, precursors for carbon-carbon, and protection systems against laser attack. Please visit cambium-usa.com.

Contact: Stephan Herrera, stephan@cambium-usa.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cambium-ranked-among-top-100-venture-funded-defense-and-dual-use-start-ups-302196432.html

SOURCE Cambium Biomaterials, Inc

Staff

Recent Posts

Campo Indictment Exposes DEA Rotted From Within – While Medical Cannabis Research and Patients Wait Seven Years

A Federal Indictment That Reads Like a Narco-State ThrillerDEA corruption reaches new levels with the…

59 minutes ago

Most Americans With OCD Never Receive Effective Treatment, Landmark Study Finds

Analysis by the International OCD Foundation highlights widespread gaps in diagnosis and care BOSTON, MASSACHUSETTS…

59 minutes ago

2026 Regulatory Crossfire: New Outlook Survey Reveals Health IT Rules Reshaping U.S. Care Delivery

Black Book Research national survey maps federal, state, and local mandates impacting hospital, physician, and…

60 minutes ago

DiagnosTear Technologies Inc. – Confirmation of No Material Change

Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

2 hours ago

Journal of Cardiac Failure December Issue Showcases Innovations in Transplant Care, Digital Therapeutics, and Global Heart Failure Treatment Strategies

WASHINGTON, Dec. 9, 2025 /PRNewswire/ -- The December issue of the Journal of Cardiac Failure (JCF),…

4 hours ago

PhyxUp Health Leads Innovation in US Rehabilitation Market with AI-Powered Remote Therapeutic Monitoring(RTM), Launches $1M Seed Funding Round

SAN FRANCISCO, Dec. 9, 2025 /PRNewswire/ -- PhyxUp Health, an AI-driven Remote Therapeutic Monitoring (RTM) platform…

4 hours ago